Tech Company Acquirers
Myrexis
Myrexis, operating out of New York, bought Javelin Pharmaceuticals.
Company Overview
Contact Information
Mailing Address
600 5th Ave. 2nd Floor
New York, NY 10020
USA
New York, NY 10020
USA
Phone
Website
Email Address
Company Background Information
Overview
Myrexis, Inc. (OTC: MYRX, formerly Myriad Pharmaceuticals) was a fully integrated biotechnology company discovering, developing and commercializing first-in-class/best-in-class products for the treatment of diseases with high unmet need such as cancer and HIV infection. In February 2012, Myrexis announced that it was shifting its strategic direction and suspended development activities of all its preclinical and clinical development programs in oncology and autoimmune diseases.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
12/21/2009
Acquisitions By Myrexis
Date
Company
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jonathan Couchman
Browse more tech company acquirers:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs